TFAP2B and Char syndrome: For both the Char syndrome variants, protein levels of TFAP2B were still detectable and comparable to the wild type (Figure 2B), which is in line with the suspected dominant negative effect previously reported for missense variants associated with this syndrome (Zhao et al.,2001).